# Confluent Medical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/confluent-medical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Scottsdale, US
- Website: www.confluentmedical.com
- Total disclosed funding: $20M
- Latest round: Series B (Apr 25, 2011)
- Investors on record: 1

## About

Confluent Medical Technologies specializes in the design and development of advanced medical devices, focusing on interventional catheter-based solutions and implants that enhance patient care.Founded in 1991 and headquartered in Scottsdale, US, Confluent Medical Technologies develops specialized medical devices. The company underwent a strategic transaction in November 2022, where its equipment manufacturing group was acquired by Medical Manufacturing Technologies, LLC and subsequently rebranded as Interface Catheter Solutions. The firm has completed a total of 4 deals, with the latest funding being a Series B round that raised USD 20.00 mn from Ampersand Capital Partners, bringing the total amount raised to USD 20.00 mn and valuing the company at USD 96.07 mn.Confluent Medical specializes in the expert design and development of advanced medical devices, particularly interventional catheter-based devices and implants. Their core offerings include Nitinol components, complex balloon catheters, high-precision polymer tubing, and implantable textiles, aimed at addressing critical health challenges and improving patient outcomes. The company serves a diverse client base of leading medical device manufacturers and healthcare providers across North America, Europe, and Asia, with a focus on applications in cardiology and vascular surgery.Operating primarily on a B2B model, Confluent Medical generates revenue through direct sales to medical device manufacturers and healthcare organizations. Clients place bulk orders based on pre-negotiated contracts that detail pricing, delivery timelines, and service agreements. Key products, such as Nitinol components and complex balloon catheters, facilitate partnerships that aid in developing essential medical solutions, with pricing reflective of the advanced engineering and materials involved.Confluent Medical plans to expand its product offerings and geographic presence. The acquisition of its equipment manufacturing group will support enhanced capabilities within the medical device sector. The funding from the Series B round will likely be directed towards developing new products and penetrating additional markets, though specific forthcoming products and timelines have not been disclosed. The company aims to leverage its recent changes to strengthen its foothold in existing and new regions.

## Funding rounds

- Series B, Apr 25, 2011, $20M — Ampersand

## Investors

- Ampersand (https://capitalatlas.ai/funds/ampersand) — Series B